Skip to main content
. 2019 Nov 22;12(1):44–50. doi: 10.3892/mco.2019.1954

Table I.

Clinicopathlogical characterstics of patients treated with FSS.

Mean age, years (range) 27.2 (12–39)
Surgical procedures, n (%)
  Cystectomy 1 (3.5)
  USO 10 (34.5)
  USO, OMT 3 (10.3)
  USO, OMT, LA 15 (51.7)
Tumor histology, n (%)
  Mucinous 16 (55.2)
  Serous 5 (17.2)
  Endometrioid 5 (17.2)
  Clear cell 3 (10.4)
Grade, an
  G1 13
  G2 10
  G3 3
FIGO stage, n (%)
  IA 14 (48.3)
  G1 6
  G2 5
  G3 2
Clear cell 1
  IC1 6 (20.7)
  G1 3
  G2 3
  G3 0
Clear cell 0
  IC3 9 (31.0)
  G1 4
  G2 2
  G3 1
  Clear cell 2
Adjuvant chemotherapy, n (%)
  Yes 19 (65.5)
  No 10 (34.5)
Recurrence, n (%)
  No 24 (82.3)
  Yes 5 (17.2)
Clinical outcome, n (%)
  NED 26 (89.7)
  AWD 1 (3.4)
  DOD 2 (6.9)
Menstruation, n
  Regular 21
  Irregular 1
  Amenorrhea 2
  Unknown 5
Reproductive outcome, bn
  Parity 7
Primary symptom, cn (%)
  Birth 6
  Abdominal symptom 24 (82.8)
  Atypical genital bleeding 3 (10.3)
  Medical examination 2 (6.9)
  Unknown 1 (3.4)
a

Clear cell is not graded.

b

Pregnancy in 5 patients, Birth in 4 patients.

c

One patient exhibited two symptoms. USO, unilateral salpingo-oophrectomy; OMT, omentectomy; LA, lymphadenectomy; NED, no evidence of disease; AWD, alive with disease; DOD, dead of disease.